Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Collegium Pharmaceutical, Inc (COLL) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Collegium Pharmaceutical, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1267565.
Total stock buying since 2015: $13,316,951.
Total stock sales since 2015: $102,016,803.
Total stock option exercises since 2015: $17,254,997.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 282,917 | $9,033,498 | 118,750 | $2,405,024 |
| 2024 | 0 | $0 | 83,358 | $2,865,462 | 28,985 | $166,084 |
| 2023 | 0 | $0 | 288,181 | $7,254,018 | 109,975 | $2,146,401 |
| 2022 | 0 | $0 | 837,724 | $18,490,189 | 528,679 | $8,246,097 |
| 2021 | 0 | $0 | 164,890 | $3,899,887 | 64,658 | $491,543 |
| 2020 | 0 | $0 | 440,349 | $9,688,885 | 364,283 | $2,330,102 |
| 2019 | 0 | $0 | 328,071 | $5,105,200 | 109,674 | $861,306 |
| 2018 | 0 | $0 | 436,091 | $10,143,803 | 97,375 | $574,042 |
| 2017 | 10,000 | $91,800 | 2,054,601 | $35,535,861 | 8,585 | $8,619 |
| 2016 | 2,375 | $25,151 | 0 | $0 | 13,604 | $25,779 |
| 2015 | 1,100,000 | $13,200,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 80,792 | $3,030,536 | 36,250 | $655,224 |
| 2025-06 | 0 | $0 | 6,601 | $202,149 | 15,000 | $201,750 |
| 2025-03 | 0 | $0 | 168,024 | $4,886,273 | 40,000 | $961,200 |
| 2025-01 | 0 | $0 | 27,500 | $914,540 | 27,500 | $586,850 |
| 2024-09 | 0 | $0 | 29,818 | $1,132,064 | 0 | $0 |
| 2024-05 | 0 | $0 | 28,985 | $936,302 | 28,985 | $166,084 |
| 2024-02 | 0 | $0 | 995 | $36,580 | 0 | $0 |
| 2024-01 | 0 | $0 | 23,560 | $760,516 | 0 | $0 |
| 2023-12 | 0 | $0 | 73,125 | $2,207,463 | 73,125 | $1,560,486 |
| 2023-11 | 0 | $0 | 25,600 | $660,019 | 25,600 | $407,040 |
| 2023-06 | 0 | $0 | 80,528 | $1,773,417 | 0 | $0 |
| 2023-05 | 0 | $0 | 62,543 | $1,368,690 | 0 | $0 |
| 2023-03 | 0 | $0 | 13,324 | $355,750 | 0 | $0 |
| 2023-02 | 0 | $0 | 33,061 | $888,679 | 11,250 | $178,875 |
| 2022-12 | 0 | $0 | 712,074 | $16,132,990 | 528,571 | $8,244,381 |
| 2022-11 | 0 | $0 | 108 | $2,376 | 108 | $1,716 |
| 2022-09 | 0 | $0 | 38,589 | $697,303 | 0 | $0 |
| 2022-08 | 0 | $0 | 300 | $6,003 | 0 | $0 |
| 2022-03 | 0 | $0 | 76,094 | $1,423,338 | 0 | $0 |
| 2022-02 | 0 | $0 | 10,559 | $228,179 | 0 | $0 |
| 2021-12 | 0 | $0 | 5,693 | $104,352 | 0 | $0 |
| 2021-05 | 0 | $0 | 7,000 | $159,390 | 0 | $0 |
| 2021-03 | 0 | $0 | 120,854 | $2,905,963 | 48,616 | $399,623 |
| 2021-02 | 0 | $0 | 7,898 | $198,318 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-29 | Smith Thomas B (EVP and Chief Medical Officer) | Sale | 17,478 | 38.42 | 671,574 |
| 2025-08-18 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 16,389 | 38.21 | 626,174 |
| 2025-08-18 | Dreyer Scott (EVP & Chief Commercial Officer) | Option Ex | 16,389 | 21.34 | 349,741 |
| 2025-08-15 | Santini Gino (Director) | Sale | 5,405 | 37.19 | 201,017 |
| 2025-08-15 | Santini Gino (Director) | Option Ex | 15,000 | 13.45 | 201,750 |
| 2025-08-13 | Rosen David Efraim | Sale | 25,000 | 37.85 | 946,250 |
| 2025-08-13 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 4,861 | 38.03 | 184,883 |
| 2025-08-13 | Dreyer Scott (EVP & Chief Commercial Officer) | Option Ex | 4,861 | 21.34 | 103,733 |
| 2025-08-08 | Freund John Gordon (Director) | Sale | 11,659 | 34.36 | 400,638 |
| 2025-06-09 | Freund John Gordon (Director) | Sale | 6,601 | 30.62 | 202,149 |
| 2025-06-09 | Freund John Gordon (Director) | Option Ex | 15,000 | 13.45 | 201,750 |
| 2025-03-21 | Tupper Colleen (EVP & Chief Financial Officer) | Sale | 6,396 | 30.03 | 192,071 |
| 2025-03-21 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 18,881 | 30.03 | 566,977 |
| 2025-03-20 | Tupper Colleen (EVP & Chief Financial Officer) | Sale | 1,206 | 30.00 | 36,181 |
| 2025-03-20 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 1,927 | 30.00 | 57,811 |
| 2025-03-14 | Tupper Colleen (EVP & Chief Financial Officer) | Sale | 977 | 30.00 | 29,312 |
| 2025-03-14 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 2,255 | 30.00 | 67,661 |
| 2025-03-11 | Tupper Colleen (EVP & Chief Financial Officer) | Sale | 10,445 | 30.01 | 313,412 |
| 2025-03-07 | Tupper Colleen (EVP & Chief Financial Officer) | Sale | 1,504 | 30.00 | 45,121 |
| 2025-03-07 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 2,348 | 30.00 | 70,447 |
| 2025-03-06 | Tupper Colleen (EVP & Chief Financial Officer) | Sale | 1,949 | 30.00 | 58,470 |
| 2025-03-06 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 18,682 | 30.00 | 560,524 |
| 2025-03-06 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 26,067 | 28.50 | 742,935 |
| 2025-03-05 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 20,000 | 28.03 | 560,520 |
| 2025-03-04 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 40,000 | 28.08 | 1,123,160 |
| 2025-03-04 | Kuhlmann Shirley R. (EVP and General Counsel) | Option Ex | 40,000 | 24.03 | 961,200 |
| 2025-01-10 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 27,500 | 33.26 | 914,540 |
| 2025-01-10 | Kuhlmann Shirley R. (EVP and General Counsel) | Option Ex | 27,500 | 21.34 | 586,850 |
| 2024-09-13 | Smith Thomas B (EVP and Chief Medical Officer) | Sale | 9,593 | 36.62 | 351,324 |
| 2024-09-06 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 977 | 37.46 | 36,594 |
| 2024-09-05 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 19,248 | 38.66 | 744,146 |
| 2024-05-14 | Bohlin Garen G (Director) | Sale | 28,985 | 32.30 | 936,302 |
| 2024-05-14 | Bohlin Garen G (Director) | Option Ex | 28,985 | 5.73 | 166,084 |
| 2024-02-29 | Smith Thomas B (EVP and Chief Medical Officer) | Sale | 995 | 36.76 | 36,580 |
| 2024-01-16 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 23,560 | 32.28 | 760,516 |
| 2023-12-21 | Ciaffoni Joseph (President and CEO) | Sale | 4,357 | 30.38 | 132,378 |
| 2023-12-21 | Ciaffoni Joseph (President and CEO) | Option Ex | 4,357 | 21.34 | 92,978 |
| 2023-12-20 | Ciaffoni Joseph (President and CEO) | Sale | 26,454 | 30.40 | 804,201 |
| 2023-12-20 | Ciaffoni Joseph (President and CEO) | Option Ex | 26,454 | 21.34 | 564,528 |
| 2023-12-19 | Ciaffoni Joseph (President and CEO) | Sale | 14,516 | 30.03 | 435,944 |
| 2023-12-19 | Ciaffoni Joseph (President and CEO) | Option Ex | 14,516 | 21.34 | 309,771 |
| 2023-12-18 | Ciaffoni Joseph (President and CEO) | Sale | 27,798 | 30.04 | 834,940 |
| 2023-12-18 | Ciaffoni Joseph (President and CEO) | Option Ex | 27,798 | 21.34 | 593,209 |
| 2023-11-27 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 25,600 | 25.78 | 660,019 |
| 2023-11-27 | Kuhlmann Shirley R. (EVP and General Counsel) | Option Ex | 25,600 | 15.90 | 407,040 |
| 2023-06-26 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 17,984 | 22.09 | 397,356 |
| 2023-06-02 | Ciaffoni Joseph (President and CEO) | Sale | 31,272 | 21.91 | 685,294 |
| 2023-06-01 | Ciaffoni Joseph (President and CEO) | Sale | 31,272 | 22.09 | 690,767 |
| 2023-05-31 | Ciaffoni Joseph (President and CEO) | Sale | 31,272 | 21.87 | 683,793 |
| 2023-05-30 | Ciaffoni Joseph (President and CEO) | Sale | 31,271 | 21.90 | 684,897 |
| 2023-03-01 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 13,324 | 26.70 | 355,750 |
| 2023-02-13 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 21,811 | 26.88 | 586,279 |
| 2023-02-13 | Ciaffoni Joseph (President and CEO) | Sale | 11,250 | 26.88 | 302,400 |
| 2023-02-13 | Ciaffoni Joseph (President and CEO) | Option Ex | 11,250 | 15.90 | 178,875 |
| 2022-12-27 | Heffernan Michael Thomas (Director) | Sale | 19,815 | 23.89 | 473,479 |
| 2022-12-27 | Heffernan Michael Thomas (Director) | Option Ex | 19,815 | 16.15 | 320,012 |
| 2022-12-27 | Ciaffoni Joseph (President and CEO) | Sale | 2,204 | 23.92 | 52,719 |
| 2022-12-23 | Heffernan Michael Thomas (Director) | Sale | 4,989 | 23.00 | 114,747 |
| 2022-12-23 | Heffernan Michael Thomas (Director) | Option Ex | 4,989 | 16.15 | 80,572 |
| 2022-12-23 | Ciaffoni Joseph (President and CEO) | Sale | 147 | 23.00 | 3,381 |
| 2022-12-22 | Heffernan Michael Thomas (Director) | Sale | 237 | 23.00 | 5,451 |
| 2022-12-22 | Heffernan Michael Thomas (Director) | Option Ex | 237 | 16.15 | 3,827 |
| 2022-12-22 | Ciaffoni Joseph (President and CEO) | Sale | 110 | 23.00 | 2,530 |
| 2022-12-21 | Heffernan Michael Thomas (Director) | Sale | 46,600 | 23.11 | 1,076,926 |
| 2022-12-21 | Heffernan Michael Thomas (Director) | Option Ex | 46,600 | 16.15 | 752,589 |
| 2022-12-21 | Ciaffoni Joseph (President and CEO) | Sale | 7,333 | 23.11 | 169,465 |
| 2022-12-20 | Heffernan Michael Thomas (Director) | Sale | 33,758 | 23.08 | 779,134 |
| 2022-12-20 | Heffernan Michael Thomas (Director) | Option Ex | 33,758 | 16.15 | 545,191 |
| 2022-12-20 | Ciaffoni Joseph (President and CEO) | Sale | 9,375 | 23.07 | 216,281 |
| 2022-12-19 | Heffernan Michael Thomas (Director) | Sale | 3,606 | 23.04 | 83,082 |
| 2022-12-19 | Heffernan Michael Thomas (Director) | Option Ex | 3,606 | 16.15 | 58,236 |
| 2022-12-19 | Ciaffoni Joseph (President and CEO) | Sale | 1,134 | 23.01 | 26,093 |
| 2022-12-13 | Heffernan Michael Thomas (Director) | Sale | 161,687 | 22.16 | 3,582,983 |
| 2022-12-13 | Heffernan Michael Thomas (Director) | Option Ex | 161,687 | 14.91 | 2,411,238 |
| 2022-12-12 | Heffernan Michael Thomas (Director) | Sale | 27,920 | 22.01 | 614,519 |
| 2022-12-12 | Heffernan Michael Thomas (Director) | Option Ex | 27,920 | 14.91 | 416,370 |
| 2022-12-02 | Ciaffoni Joseph (President and CEO) | Sale | 108,800 | 23.07 | 2,510,016 |
| 2022-12-01 | Ciaffoni Joseph (President and CEO) | Sale | 153,306 | 22.47 | 3,444,784 |
| 2022-12-01 | Ciaffoni Joseph (President and CEO) | Option Ex | 153,306 | 15.90 | 2,437,564 |
| 2022-11-28 | Ciaffoni Joseph (President and CEO) | Sale | 43 | 22.00 | 946 |
| 2022-11-28 | Ciaffoni Joseph (President and CEO) | Option Ex | 43 | 15.90 | 683 |
| 2022-11-22 | Ciaffoni Joseph (President and CEO) | Sale | 65 | 22.00 | 1,430 |
| 2022-11-22 | Ciaffoni Joseph (President and CEO) | Option Ex | 65 | 15.90 | 1,033 |
| 2022-09-15 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 38,589 | 18.07 | 697,303 |
| 2022-08-11 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 300 | 20.01 | 6,003 |
| 2022-03-01 | Ciaffoni Joseph (President and CEO) | Sale | 76,094 | 18.70 | 1,423,338 |
| 2022-02-18 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 10,559 | 21.61 | 228,179 |
| 2021-12-15 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 5,693 | 18.33 | 104,352 |
| 2021-05-10 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 7,000 | 22.77 | 159,390 |
| 2021-03-15 | Heffernan Michael Thomas | Sale | 50,075 | 25.57 | 1,280,417 |
| 2021-03-01 | Fleming Alison B (Chief Technical Officer) | Sale | 6,011 | 23.36 | 140,416 |
| 2021-03-01 | Ciaffoni Joseph (President and CEO) | Sale | 64,768 | 22.93 | 1,485,130 |
| 2021-03-01 | Ciaffoni Joseph (President and CEO) | Option Ex | 48,616 | 8.22 | 399,623 |
| 2021-02-11 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 7,898 | 25.11 | 198,318 |
| 2021-01-20 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 6,081 | 24.45 | 148,680 |
| 2021-01-15 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 1,322 | 22.89 | 30,260 |
| 2021-01-07 | Fleming Alison B (Chief Technology Officer) | Sale | 16,042 | 22.00 | 352,924 |
| 2021-01-07 | Fleming Alison B (Chief Technology Officer) | Option Ex | 16,042 | 5.73 | 91,920 |
| 2020-12-03 | Fleming Alison B (Chief Technology Officer) | Sale | 5,967 | 19.24 | 114,805 |
| 2020-11-18 | Fleming Alison B (Chief Technology Officer) | Option Ex | 16,000 | 5.73 | 91,680 |
| 2020-10-15 | Kuhlmann Shirley R. (EVP and General Counsel) | Sale | 7,060 | 20.82 | 146,989 |
| 2020-08-11 | Heffernan Michael Thomas | Sale | 13,071 | 19.13 | 250,048 |
| 2020-07-13 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 1,429 | 17.01 | 24,307 |
| 2020-06-02 | Ciaffoni Joseph (President and CEO) | Sale | 5,861 | 20.89 | 122,406 |
| 2020-06-01 | Ciaffoni Joseph (President and CEO) | Sale | 70,676 | 21.80 | 1,541,090 |
| 2020-06-01 | Ciaffoni Joseph (President and CEO) | Option Ex | 64,820 | 8.22 | 532,820 |
| 2020-05-18 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 8,000 | 24.00 | 192,000 |
| 2020-05-18 | Dreyer Scott (EVP & Chief Commercial Officer) | Option Ex | 8,000 | 15.90 | 127,200 |
| 2020-05-13 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 4,434 | 22.61 | 100,252 |
| 2020-05-13 | Fleming Alison B (Chief Technology Officer) | Sale | 7,989 | 21.93 | 175,198 |
| 2020-05-13 | Heffernan Michael Thomas | Sale | 19,254 | 21.59 | 415,693 |
| 2020-01-21 | Heffernan Michael Thomas (Director) | Sale | 295,287 | 22.27 | 6,574,565 |
| 2020-01-21 | Heffernan Michael Thomas (Director) | Option Ex | 275,463 | 5.73 | 1,578,402 |
| 2020-01-14 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 1,321 | 23.87 | 31,532 |
| 2019-11-08 | Fleming Alison B (Chief Technology Officer) | Sale | 25,000 | 19.44 | 486,000 |
| 2019-11-08 | Fleming Alison B (Chief Technology Officer) | Option Ex | 25,000 | 5.73 | 143,250 |
| 2019-11-08 | Hirsch David (Director) | Sale | 25,000 | 19.33 | 483,249 |
| 2019-11-07 | Ciaffoni Joseph (President and CEO) | Sale | 64,821 | 18.79 | 1,217,662 |
| 2019-11-07 | Ciaffoni Joseph (President and CEO) | Option Ex | 64,821 | 8.22 | 532,828 |
| 2019-08-29 | Hirsch David (Director) | Sale | 22,106 | 11.65 | 257,534 |
| 2019-08-29 | Hirsch David (Director) | Option Ex | 19,853 | 9.33 | 185,228 |
| 2019-07-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 11.26 | 281,500 |
| 2019-07-11 | Dreyer Scott (EVP & Chief Commercial Officer) | Sale | 2,857 | 12.31 | 35,169 |
| 2019-06-17 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 11.68 | 292,000 |
| 2019-06-03 | Ciaffoni Joseph (President and CEO) | Sale | 7,436 | 11.59 | 86,183 |
| 2019-05-31 | Ciaffoni Joseph (President and CEO) | Sale | 5,851 | 11.52 | 67,403 |
| 2019-05-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 12.94 | 323,375 |
| 2019-04-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 15.39 | 384,750 |
| 2019-03-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 17.17 | 429,250 |
| 2019-02-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 14.88 | 372,125 |
| 2019-01-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 15.56 | 389,000 |
| 2018-12-17 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 18.34 | 458,625 |
| 2018-11-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 16.79 | 419,750 |
| 2018-10-15 | Heffernan Michael Thomas (Director) | Sale | 25,000 | 16.53 | 413,250 |
| 2018-06-21 | Brannelly Paul (Executive Vice President & CFO) | Sale | 10,000 | 27.93 | 279,250 |
| 2018-06-12 | Fleming Alison B (Chief Technology Officer) | Sale | 4,096 | 27.00 | 110,592 |
| 2018-06-12 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 53,057 | 25.26 | 1,340,219 |
| 2018-06-11 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 96,943 | 25.28 | 2,450,719 |
| 2018-06-01 | Ciaffoni Joseph (Chief Operating Officer) | Sale | 14,862 | 22.48 | 334,097 |
| 2018-05-31 | Ciaffoni Joseph (Chief Operating Officer) | Sale | 64,821 | 22.95 | 1,487,317 |
| 2018-05-31 | Ciaffoni Joseph (Chief Operating Officer) | Option Ex | 64,821 | 8.22 | 532,828 |
| 2018-05-10 | Fleming Alison B (Chief Technical Officer) | Sale | 1,400 | 27.00 | 37,800 |
| 2018-05-10 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 7,100 | 26.50 | 188,150 |
| 2018-04-19 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 44,400 | 26.00 | 1,154,622 |
| 2018-04-02 | Fleming Alison B (Chief Technology Officer) | Option Ex | 8,142 | .28 | 2,279 |
| 2018-01-23 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 16,408 | 25.01 | 410,364 |
| 2018-01-22 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 3,592 | 25.00 | 89,800 |
| 2018-01-19 | Fleming Alison B (Chief Technology Officer) | Sale | 6,660 | 23.00 | 153,180 |
| 2018-01-19 | Fleming Alison B (Chief Technology Officer) | Option Ex | 6,660 | 3.72 | 24,775 |
| 2018-01-19 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 20,000 | 22.50 | 450,000 |
| 2018-01-12 | Fleming Alison B (Chief Technical Officer) | Sale | 7,500 | 21.00 | 157,500 |
| 2018-01-12 | Fleming Alison B (Chief Technical Officer) | Option Ex | 7,500 | .69 | 5,175 |
| 2018-01-10 | Fleming Alison B (Chief Technology Officer) | Sale | 6,928 | 19.07 | 132,116 |
| 2018-01-10 | Fleming Alison B (Chief Technology Officer) | Option Ex | 6,928 | .48 | 3,325 |
| 2017-12-08 | Hirsch David (Director) | Sale | 1,000,000 | 17.34 | 17,340,000 |
| 2017-12-08 | Longitude Venture Partners L.p. (10% Owner) | Sale | 1,000,000 | 17.34 | 17,340,000 |
| 2017-11-21 | Fleming Alison B (Chief Technology Officer) | Sale | 572 | 19.00 | 10,868 |
| 2017-11-21 | Fleming Alison B (Chief Technology Officer) | Option Ex | 572 | .28 | 160 |
| 2017-11-17 | Fleming Alison B (Chief Technology Officer) | Sale | 4,029 | 17.00 | 68,493 |
| 2017-11-17 | Fleming Alison B (Chief Technology Officer) | Option Ex | 3,189 | .28 | 892 |
| 2017-11-15 | Heffernan Michael Thomas (Chairman, President and CEO) | Sale | 50,000 | 15.53 | 776,500 |
| 2017-10-25 | Fleming Alison B (Chief Technology Officer) | Option Ex | 1,811 | 3.38 | 6,121 |
| 2017-05-12 | Brannelly Paul (Executive Vice President & CFO) | Buy | 10,000 | 9.18 | 91,800 |
| 2017-01-31 | Heffernan Michael Thomas (Chairman, President and CEO) | Option Ex | 3,013 | .48 | 1,446 |
| 2016-08-12 | Fallon John A. (Director) | Buy | 2,375 | 10.59 | 25,151 |
| 2016-04-05 | Heffernan Michael Thomas (Chairman, President and CEO) | Option Ex | 13,604 | 1.90 | 25,779 |
| 2015-05-12 | Hirsch David (Director) | Buy | 200,000 | 12.00 | 2,400,000 |
| 2015-05-12 | Every Nathan R (10% Owner) | Buy | 150,000 | 12.00 | 1,800,000 |
| 2015-05-12 | Heron Patrick J (Director) | Buy | 150,000 | 12.00 | 1,800,000 |
| 2015-05-12 | Freund John Gordon (Director) | Buy | 150,000 | 12.00 | 1,800,000 |
| 2015-05-12 | Kaneko Yasunori (10% Owner) | Buy | 150,000 | 12.00 | 1,800,000 |
| 2015-05-12 | Enright Patrick G (10% Owner) | Buy | 200,000 | 12.00 | 2,400,000 |
| 2015-05-12 | Coulter James G | Buy | 100,000 | 12.00 | 1,200,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of COLL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Collegium Pharmaceutical, Inc (symbol COLL, CIK number 1267565) see the Securities and Exchange Commission (SEC) website.